Patent analysis of digital sensors for continuous glucose monitoring.
Ontology highlight
ABSTRACT: The high need for optimal diabetes management among an ever-increasing number of patients dictates the development and implementation of new digital sensors for continuous glucose monitoring. The purpose of this work is to systematize the global patenting trends of digital sensors for continuous glucose monitoring and analyze their effectiveness in controlling the treatment of diabetes patients of different ages and risk groups. The Lens database was used to build the patent landscape of sensors for continuous glucose monitoring. Retrospective analysis showed that the patenting of sensors for continuous glucose monitoring had positive trend over the analyzed period (2000-2022). Leading development companies are Dexcom Inc., Abbott Diabetes Care Inc., Medtronic Minimed Inc., Roche Diabetes
SUBMITTER: Litvinova O
PROVIDER: S-EPMC10445130 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA